wire - news in brief
Category
Results 1 - 50 of 447.
CHEOPS describes one of the most extreme planets in the universe
CHEOPS keeps its promise: Observations with the space telescope reveal details of the exoplanet WASP-189b - one of the most extreme planets known. CHEOPS is a joint mission by the European Space Agency (ESA) and Switzerland, under the aegis of the University of Bern in collaboration with the University of Geneva.
CHEOPS keeps its promise: Observations with the space telescope reveal details of the exoplanet WASP-189b - one of the most extreme planets known. CHEOPS is a joint mission by the European Space Agency (ESA) and Switzerland, under the aegis of the University of Bern in collaboration with the University of Geneva.
CHEOPS keeps its promise: Observations with the space telescope reveal details of the exoplanet WASP-189b - one of the most extreme planets known. CHEOPS is a joint mission by the European Space Agency (ESA) and Switzerland, under the aegis of the University of Bern in collaboration with the University of Geneva.
Yes, we’re worried
Climate activists were sentenced yesterday in the second instance. Sonia Seneviratne explains why climate researchers got involved in this trial and expressed their views in a public statement.
Climate activists were sentenced yesterday in the second instance. Sonia Seneviratne explains why climate researchers got involved in this trial and expressed their views in a public statement.
The Swiss Confederation joins the COVAX initiative for the procurement of COVID-19 vaccines
Switzerland commits to promoting a global solution for the equitable distribution of Covid-19 vaccines.
Switzerland commits to promoting a global solution for the equitable distribution of Covid-19 vaccines.
Novartis Provides Update on AVXS-101 Intrathecal Clinical Development Program
Novartis Gene Therapies to initiate new pivotal confirmatory study to evaluate use of AVXS-101 intrathecal (I T) formulation in older patients with SMA to further support registration Basel, Septembe
Novartis Gene Therapies to initiate new pivotal confirmatory study to evaluate use of AVXS-101 intrathecal (I T) formulation in older patients with SMA to further support registration Basel, Septembe
Most people infected with SARS-CoV-2 develop symptoms
While some people who contract SARS-CoV-2 infections never experience any symptoms, there remains disagreement about what proportion of total infections these cases comprise.
While some people who contract SARS-CoV-2 infections never experience any symptoms, there remains disagreement about what proportion of total infections these cases comprise.
Loading of replicative helicases onto DNA is a key event during the initiation of chromosomal DNA replication.
Novartis Kisqali receives the highest rating of any CDK4/6 inhibitor on the ESMO Magnitude of Clinical Benefit Scale
Kisqali is the only CDK4/6 inhibitor, in combination with endocrine therapy, to achieve a perfect 5 out of 5 score - confirming substantial benefit for premenopausal women with HR+/HER2- advanced bre
Kisqali is the only CDK4/6 inhibitor, in combination with endocrine therapy, to achieve a perfect 5 out of 5 score - confirming substantial benefit for premenopausal women with HR+/HER2- advanced bre
Patches to detect when a viral disease is about to get worse
Xsensio, an EPFL spin-off, has just been awarded CHF 1.8 million in EU funding to adapt its Lab-on-Skin(TM) sensing patches so that they can detect when a viral illness like the flu or COVID-19 is about to get worse.
Xsensio, an EPFL spin-off, has just been awarded CHF 1.8 million in EU funding to adapt its Lab-on-Skin(TM) sensing patches so that they can detect when a viral illness like the flu or COVID-19 is about to get worse.
To cut food waste, we may need to pay more for what we eat
How can we reduce food waste? Although the Swiss population are aware of the problem, they misjudge where most food waste is generated, ETH political scientists conclude.
How can we reduce food waste? Although the Swiss population are aware of the problem, they misjudge where most food waste is generated, ETH political scientists conclude.
Speeding out of lockdown
Swissloop, the team of students developing hyperloop pods, took advantage of the break imposed by the coronavirus to improve the technology even further. Yesterday they unveiled their "research pod". At its core lies a technologically refined linear motor that will propel future prototypes at even faster speeds.
Swissloop, the team of students developing hyperloop pods, took advantage of the break imposed by the coronavirus to improve the technology even further. Yesterday they unveiled their "research pod". At its core lies a technologically refined linear motor that will propel future prototypes at even faster speeds.
HIV continues to be a major global health issue, having claimed almost 33 million lives.
Novartis Tafinlar + Mekinist demonstrates long-term, relapse-free survival benefit for high-risk, stage III melanoma patients in study published in NEJM
COMBI-AD is first trial to demonstrate 5-year relapse-free survival with targeted therapy as adjuvant treatment in high-risk patients with stage III BRAF-mutated melanoma 1 Adjuvant treatment with
COMBI-AD is first trial to demonstrate 5-year relapse-free survival with targeted therapy as adjuvant treatment in high-risk patients with stage III BRAF-mutated melanoma 1 Adjuvant treatment with
Catalyst Fund selects six projects in its 2020 funding round
The Catalyst Fund - supported by the Bertarelli Foundation - has selected six research projects to fund this year. Led by professors from EPFL and other Swiss Universities, these projects all aim to develop new treatment options for neurological disorders. Created by the Bertarelli Foundation in 2017, the Catalyst Fund aims to invest in translational projects targeting innovative approaches for diseases affecting the brain, spinal cord, peripheral nervous system and sensory organs.
The Catalyst Fund - supported by the Bertarelli Foundation - has selected six research projects to fund this year. Led by professors from EPFL and other Swiss Universities, these projects all aim to develop new treatment options for neurological disorders. Created by the Bertarelli Foundation in 2017, the Catalyst Fund aims to invest in translational projects targeting innovative approaches for diseases affecting the brain, spinal cord, peripheral nervous system and sensory organs.
Living at home in old age: This is what most older adults want. As a result, there is a high demand for senior apartments and tailor-made services for the care of older adults in need of assistance in their own households.
One application in which Brandao and the IT Services team have opted for AI is a key piece of research infrastructure known as the Leonhard cluster, which is specially designed for big data analytics and machine learning. "It offers features unmatched by any other cluster in the world and is very popular in biomedical research and other areas," says Brandao.
Protecting citizens in the face of disaster often requires far-reaching decisions to be made. Any assistance is welcome - including from AI.
Artificial intelligence is having a growing impact on our daily lives and is also revolutionising research.
A bioethicist and a neuroinformatics scientist discuss how machines are becoming more intelligent and why the advances in technology are leading to new ethical challenges.
The Inga hope a university will keep their indigenous heritage alive, safeguard the natural habitat of the Colombian rainforest and give the younger generation a future.
European Medicines Agency (EMA) approves safety label update for Novartis Beovu
Novartis worked with the EMA to update the Beovu (brolucizumab) label to guide physicians in their treatment of wet AMD The update includes the additional characterization of retinal vasculitis a
Novartis worked with the EMA to update the Beovu (brolucizumab) label to guide physicians in their treatment of wet AMD The update includes the additional characterization of retinal vasculitis a
Putting the users centre stage
Even if we succeed in combatting the COVID crisis, the challenges for the health system will not simply disappear. Digital technologies can be developed to help meet ongoing challenges; Nicole Wenderoth explains what should be borne in mind here. Across the globe, the COVID-19 pandemic has pushed healthcare systems to their limits, at least for the moment.
Even if we succeed in combatting the COVID crisis, the challenges for the health system will not simply disappear. Digital technologies can be developed to help meet ongoing challenges; Nicole Wenderoth explains what should be borne in mind here. Across the globe, the COVID-19 pandemic has pushed healthcare systems to their limits, at least for the moment.
"Science Wire" gives access to latest science news from universities, research centers and R&D companies.Add this page to your bookmarks
